不妊治療市場規模、シェア、成長分析、製品別、手技別、患者タイプ別、エンドユーザー別、地域別-2025～2032年産業予測

不妊治療市場規模は2023年に38億米ドルとなり、予測期間（2025～2032年）のCAGRは6.9%で、2024年の40億6,000万米ドルから2032年には69億3,000万米ドルに成長する展望です。

世界の不妊治療市場は、不妊率の上昇、妊産婦の高齢化、ライフスタイルの変化、著しい技術革新などを背景に、近年急増しています。不妊症の蔓延は人口のかなりの部分を占め、効果的な治療オプションに対する需要の高まりにつながっています。体外受精（IVF）や顕微授精（ICSI）などの生殖補助医療（ART）は、不妊の課題に直面しているカップルの間で人気を博しています。これらの技術の継続的な進歩により、成功率と患者の転帰が改善されています。これらの技術がより身近で手ごろなものになるにつれて、市場はさらに成長すると予想されます。さらに、第三者による生殖方法の受け入れの増加、可処分所得の増加、親になることを先延ばしにする動向などの要因も、市場の勢いを後押ししています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 規制分析
• 技術分析

不妊治療市場規模：製品別&CAGR（2025～2032年）

• 市場概要
• 装置
  • 顕微鏡
  • イメージングシステム
  • 精子分析システム
  • 卵子吸引ポンプ
  • マイクロマニピュレーターシステム
  • インキュベーター
  • ガス分析装置
  • レーザーシステム
  • クライオシステム
  • 精子分離装置
• メディアと消耗品
• 付属品

不妊治療市場規模：手技別&CAGR（2025～2032年）

• 市場概要
• 生殖補助医療
  • 体外受精
  • 卵細胞質内精子注入
  • 代理出産
• 人工授精
  • 子宮内人工授精
  • 子宮頸管内授精
  • 卵管内人工授精
• 不妊治療手術
  • 腹腔鏡検査
  • 子宮鏡検査
  • 子宮筋腫摘出術
  • 開腹手術
  • 卵管結紮解除
  • 静脈瘤切除術
  • 顕微手術による再建
  • 血管吻合術
  • 精管精巣吻合術
• その他の不妊治療手順

不妊治療市場規模：患者タイプ別&CAGR（2025～2032年）

• 市場概要
• 女性不妊治療
• 男性不妊治療

不妊治療市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 不妊治療センター
• 病院と外科クリニック
• クライオバンク
• 研究機関

不妊治療市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

    主要企業プロファイル

    • CooperSurgical, Inc.（米国）
    • Vitrolife（スウェーデン）
    • FUJIFILM Irvine Scientific（日本）
    • Thermo Fisher Scientific, Inc.（米国）
    • Cook Medical Inc.（米国）
    • Hamilton Thorne Ltd.（米国）
    • Esco Micro Pte. Ltd.（シンガポール）
    • Genea Biomedx（オーストラリア）
    • Merck KGaA（ドイツ）
    • Ferring Pharmaceuticals（スイス）
    • Organon & Co.（米国）
    • Abbott Laboratories（米国）
    • Novartis AG（スイス）
    • Bayer AG（ドイツ）
    • Indira IVF（インド）
    • Fairhaven Health（米国）
    • Theralogix（米国）
    • VitabIoTics Ltd.（英国）
    • Exeltis（スペイン）
    • Zita West（英国）

結論と提言

Infertility Treatment Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.06 billion in 2024 to USD 6.93 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global infertility treatment market has surged in recent years, driven by rising infertility rates, advanced maternal age, lifestyle changes, and significant technological innovations. The prevalence of infertility affects a substantial portion of the population, leading to an increasing demand for effective treatment options. Assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have gained popularity among couples facing infertility challenges. Continuous advancements in these techniques have resulted in improved success rates and patient outcomes. The market is expected to grow further as these technologies become more accessible and affordable. Additionally, factors like the rising acceptance of third-party reproduction methods, increasing disposable incomes, and the trend of postponing parenthood are also driving market momentum.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segments Analysis

Global Infertility Treatment Market is segmented by Product, Procedure, Patient Type, End User and region. Based on Product, the market is segmented into Equipment, Media & Consumables and Accessories. Based on Procedure, the market is segmented into Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries and Other Infertility Treatment Procedures. Based on Patient Type, the market is segmented into Female Infertility Treatment and Male Infertility Treatment. Based on End User, the market is segmented into Fertility Centers, Hospitals & Surgical Clinics, Cryobanks and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infertility Treatment Market

The infertility treatment market is experiencing significant growth driven by several factors, including global increases in infertility rates attributed to lifestyle changes, delayed parenthood, and environmental factors. As more individuals and couples encounter fertility challenges, the demand for treatment options continues to rise. Moreover, advancements in medical technology, particularly in assisted reproductive techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have notably improved success rates, rendering these treatments more effective and accessible. Consequently, the combination of rising infertility issues and enhanced technological capabilities is fueling the expansion of the infertility treatment market.

Restraints in the Infertility Treatment Market

A significant constraint in the infertility treatment market is the high cost associated with advanced therapies such as in vitro fertilization (IVF) and genetic testing. This financial burden limits access to these essential services for a large segment of the population. Additionally, ethical dilemmas related to assisted reproductive technologies-such as concerns over embryo manipulation and the moral considerations of surrogacy-add further complications that can hinder market growth. These factors collectively create barriers that impact the affordability and acceptance of infertility treatments, thereby restricting market expansion and accessibility for those in need.

Market Trends of the Infertility Treatment Market

The infertility treatment market is witnessing a significant trend characterized by rising consumer awareness and the growing utilization of precision medicine in approaches like in vitro fertilization (IVF). Advances in genetic testing and embryo screening have become essential, allowing for a more targeted and personalized selection process that increases the chances of successful implantation while minimizing genetic risks. Moreover, there is a notable shift toward the acceptance of third-party reproductive methods, such as surrogacy and gamete donation, which offer alternative pathways to parenthood. This increased openness is broadening the market's appeal and fostering innovative solutions for couples facing infertility challenges.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis
• Technology Analysis

Global Infertility Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
• Media & Consumables
• Accessories

Global Infertility Treatment Market Size by Procedure & CAGR (2025-2032)

• Market Overview
• Assisted Reproductive Technology
  • In Vitro Fertilization
  • Intracytoplasmic Sperm Injection
  • Surrogacy
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
• Fertility Surgeries
  • Laparoscopy
  • Hysteroscopy
  • Myomectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Varicocelectomy
  • Microsurgical Reconstruction
  • Vasovasostomy
  • Vasoepididymostomy
• Other Infertility Treatment Procedures

Global Infertility Treatment Market Size by Patient Type & CAGR (2025-2032)

• Market Overview
• Female Infertility Treatment
• Male Infertility Treatment

Global Infertility Treatment Market Size by End User & CAGR (2025-2032)

• Market Overview
• Fertility Centers
• Hospitals & Surgical Clinics
• Cryobanks
• Research Institutes

Global Infertility Treatment Market Size & CAGR (2025-2032)

• North America (Product, Procedure, Patient Type, End User)
  • US
  • Canada
• Europe (Product, Procedure, Patient Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure, Patient Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure, Patient Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Patient Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Micro Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Biomedx (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indira IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fairhaven Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theralogix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitabiotics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exeltis (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zita West (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations